Accéder au contenu
Merck

Using gold nanobeacons as a theranostic technique to recognize, detect, and inhibit specific nucleic acids.

STAR protocols (2023-01-04)
Diana Pacheco Sousa, João Conde
RÉSUMÉ

This protocol describes the synthesis and characterization of gold nanoparticle-based nanobeacons as a theranostic strategy for the recognition, detection, and inhibition of miRNA and mRNA. This system is designed for an in vitro evaluation of a sequence's silencing potential and later used for cellular and in vivo gene silencing approaches using fluorescence imaging, enhancing theranostic procedures in which nanoparticle-based sensors and inhibitors may provide simultaneous detection of different gene-associated conditions and nanodevices for a real-time monitoring of gene delivery. For complete details on the use and execution of this protocol, please refer to Conde et al. (2015, 2013).1,2.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Roche
DNase I, grade II, from bovine pancreas
Roche
RNase, DNase-free, High Concentration, from bovine pancreas